Global Injectable Viscosupplementation Market Research Report 2023

Publication ID:

PB510237495

Publication Date:

October 4, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
The global Injectable Viscosupplementation market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Injectable Viscosupplementation 91制片厂.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Injectable Viscosupplementation market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Injectable Viscosupplementation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Injectable Viscosupplementation Market Overview
1.1 Product Overview and Scope of Injectable Viscosupplementation
1.2 Injectable Viscosupplementation Segment by Type
1.2.1 Global Injectable Viscosupplementation Market Value Comparison by Type (2023-2029)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Injectable Viscosupplementation Segment by Application
1.3.1 Global Injectable Viscosupplementation Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Injectable Viscosupplementation Market Size Estimates and Forecasts
1.4.1 Global Injectable Viscosupplementation Revenue 2018-2029
1.4.2 Global Injectable Viscosupplementation Sales 2018-2029
1.4.3 Global Injectable Viscosupplementation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Injectable Viscosupplementation Market Competition by Manufacturers
2.1 Global Injectable Viscosupplementation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Injectable Viscosupplementation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Injectable Viscosupplementation Average Price by Manufacturers (2018-2023)
2.4 Global Injectable Viscosupplementation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Injectable Viscosupplementation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Viscosupplementation, Product Type & Application
2.7 Injectable Viscosupplementation Market Competitive Situation and Trends
2.7.1 Injectable Viscosupplementation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Viscosupplementation Players Market Share by Revenue
2.7.3 Global Injectable Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Viscosupplementation Retrospective Market Scenario by Region
3.1 Global Injectable Viscosupplementation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Injectable Viscosupplementation Global Injectable Viscosupplementation Sales by Region: 2018-2029
3.2.1 Global Injectable Viscosupplementation Sales by Region: 2018-2023
3.2.2 Global Injectable Viscosupplementation Sales by Region: 2024-2029
3.3 Global Injectable Viscosupplementation Global Injectable Viscosupplementation Revenue by Region: 2018-2029
3.3.1 Global Injectable Viscosupplementation Revenue by Region: 2018-2023
3.3.2 Global Injectable Viscosupplementation Revenue by Region: 2024-2029
3.4 North America Injectable Viscosupplementation Market Facts & Figures by Country
3.4.1 North America Injectable Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Injectable Viscosupplementation Sales by Country (2018-2029)
3.4.3 North America Injectable Viscosupplementation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Viscosupplementation Market Facts & Figures by Country
3.5.1 Europe Injectable Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Injectable Viscosupplementation Sales by Country (2018-2029)
3.5.3 Europe Injectable Viscosupplementation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Viscosupplementation Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Injectable Viscosupplementation Sales by Country (2018-2029)
3.6.3 Asia Pacific Injectable Viscosupplementation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Injectable Viscosupplementation Market Facts & Figures by Country
3.7.1 Latin America Injectable Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Injectable Viscosupplementation Sales by Country (2018-2029)
3.7.3 Latin America Injectable Viscosupplementation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Viscosupplementation Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Injectable Viscosupplementation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Injectable Viscosupplementation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Viscosupplementation Sales by Type (2018-2029)
4.1.1 Global Injectable Viscosupplementation Sales by Type (2018-2023)
4.1.2 Global Injectable Viscosupplementation Sales by Type (2024-2029)
4.1.3 Global Injectable Viscosupplementation Sales Market Share by Type (2018-2029)
4.2 Global Injectable Viscosupplementation Revenue by Type (2018-2029)
4.2.1 Global Injectable Viscosupplementation Revenue by Type (2018-2023)
4.2.2 Global Injectable Viscosupplementation Revenue by Type (2024-2029)
4.2.3 Global Injectable Viscosupplementation Revenue Market Share by Type (2018-2029)
4.3 Global Injectable Viscosupplementation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Injectable Viscosupplementation Sales by Application (2018-2029)
5.1.1 Global Injectable Viscosupplementation Sales by Application (2018-2023)
5.1.2 Global Injectable Viscosupplementation Sales by Application (2024-2029)
5.1.3 Global Injectable Viscosupplementation Sales Market Share by Application (2018-2029)
5.2 Global Injectable Viscosupplementation Revenue by Application (2018-2029)
5.2.1 Global Injectable Viscosupplementation Revenue by Application (2018-2023)
5.2.2 Global Injectable Viscosupplementation Revenue by Application (2024-2029)
5.2.3 Global Injectable Viscosupplementation Revenue Market Share by Application (2018-2029)
5.3 Global Injectable Viscosupplementation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Injectable Viscosupplementation Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Anika Therapeutics Injectable Viscosupplementation Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Seikagaku Injectable Viscosupplementation Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Injectable Viscosupplementation Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bioventus Injectable Viscosupplementation Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ferring Injectable Viscosupplementation Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LG Chem Injectable Viscosupplementation Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Freda Injectable Viscosupplementation Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haohai Biological Injectable Viscosupplementation Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Injectable Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Jingfeng Injectable Viscosupplementation Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Viscosupplementation Industry Chain Analysis
7.2 Injectable Viscosupplementation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Viscosupplementation Production Mode & Process
7.4 Injectable Viscosupplementation Sales and Marketing
7.4.1 Injectable Viscosupplementation Sales Channels
7.4.2 Injectable Viscosupplementation Distributors
7.5 Injectable Viscosupplementation Customers
8 Injectable Viscosupplementation Market Dynamics
8.1 Injectable Viscosupplementation Industry Trends
8.2 Injectable Viscosupplementation Market Drivers
8.3 Injectable Viscosupplementation Market Challenges
8.4 Injectable Viscosupplementation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.